@article{4ba1694d04f3498bbfc573517245b68a,
title = "Targeting hexokinase 2 in castration-resistant prostate cancer",
abstract = "Aerobic glycolysis, known as the Warburg effect, is one of the hallmarks of cancer cells. We recently reported that the hexokinase 2 (HK2)-mediated Warburg effect is required for castration-resistant prostate cancer that is driven by Pten/p53 deficiency, suggesting that HK2 might be a therapeutic target for prostate cancer patients carrying PTEN and p53 mutations.",
author = "Yibin Deng and Junxuan Lu",
note = "Funding Information: This work was supported, in part, by grants from the US National Cancer Institute (R01 CA160333, YD; R21 CA155522, YD and JL; R01 CA172169, JL and YD), The University of Minnesota Grant-in Aid (YD) and start-up funds from The Hormel Foundation (YD). Publisher Copyright: {\textcopyright} 2015, {\textcopyright} 2015 The Author(s). Published with license by Taylor & Francis Group, LLC. {\textcopyright} 2015, {\textcopyright} Yibin Deng and Junxuan Lu.",
year = "2015",
month = jul,
day = "3",
doi = "10.4161/23723556.2014.974465",
language = "English (US)",
volume = "2",
journal = "Molecular and Cellular Oncology",
issn = "2372-3556",
publisher = "Taylor and Francis Ltd.",
number = "3",
}